Progressive deterioration of α4β2nicotinic acetylcholine receptor (α4β2-nAChR) binding in de novo Parkinson's disease: A 1-year follow-up 2-[18F]F-A-85380 (2-FA) PET study

被引：0

作者：

Meyer, Philipp ^{[1
]}

Becker, Georg ^{[1
]}

Hesse, Swen ^{[1
]}

Wegner, Florian ^{[2
]}

Patt, Marianne ^{[1
]}

Barthel, Henryk ^{[1
]}

Gertz, Hermann-Josef ^{[3
]}

Sabri, Osama ^{[1
]}

机构：

[1] Univ Leipzig, Nucl Med, D-04109 Leipzig, Germany

[2] Hannover Med Sch, Neurol, Hannover, Germany

[3] Univ Leipzig, Psychiat, D-04109 Leipzig, Germany

来源：

JOURNAL OF NUCLEAR MEDICINE | 2014年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

301

引用

页数：1

共 50 条

[1] Progressive decline of α4β2*nicotinic acetylcholine receptor binding in de novo Parkinson's disease: a 1-year follow-up 2-[18F]F-A-85380 PET study
Meyer, P. M.
Becker, G. A.
Hesse, S.
Wegner, F.
Patt, M.
Barthel, H.
Gertz, H.
Sabril, O.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S275 - S275
[2] α4β2*nicotinic acetylcholine receptor (α4β2*-nAChR) binding in acute unmedicated major depressive disorder: A 2-[18F]F-A-85380 (2-FA) PET study
Meyer, Philipp
Hegerl, Ulrich
Hesse, Swen
Becker, Georg
Strauss, Maria
Patt, Marianne
Rullmann, Michael
Barthel, Henryk
Schoenknecht, Peter
Sabri, Osama
JOURNAL OF NUCLEAR MEDICINE, 2014, 55
[3] Influence of APOE ε4 genotype on α4β2*nicotinic acetylcholine receptor binding (α4β2*-nAChR) and cognitive dysfunction in Parkinson's disease (PD): a 2-[18F]F-A-85380 (2-FA) PET study
Meyer, Philipp
Becker, Georg
Hesse, Swen
Patt, Marianne
Burkhardt, Ralph
Barthel, Henryk
Wegner, Florian
Sabri, Osama
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
[4] α4β2*Nicotinic acetylcholine receptor binding in Parkinson's disease with mild cognitive impairment using 2-[18F]F-A-85380 PET
Meyer, P. M.
Hesse, S.
Becker, G.
Kendziorra, K.
Gertz, H.
Schwarz, J.
Sabri, O.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S179 - S180
[5] Lower α4β2*nicotinic acetylcholine receptor (α4β2*-nAChR) binding in dementia associated with Parkinson's disease (PDD) compared with Alzheimer's disease (AD): A 2-[18F]F-A-85380 (2FA)-PET study
Meyer, Philipp
Gertz, Hermann-Josef
Wegner, Florian
Hesse, Swen
Barthel, Henryk
Strecker, Karl
Patt, M.
Sabri, Osama
JOURNAL OF NUCLEAR MEDICINE, 2012, 53
[6] 2-[18F]F-A-85380:: a PET radioligand for α4β2 nicotinic acetylcholine receptors
Chefer, SI
Horti, AG
Koren, AO
Gündisch, D
Links, JM
Kurian, V
Dannals, RF
Mukhin, AG
London, ED
NEUROREPORT, 1999, 10 (13) : 2715 - 2721
[7] α4β2*Nicotinic acetylcholine receptor (α4β2*) binding in dementia associated with Parkinson's disease: A 2-[18F]F-A85380 (2FA)-PET study
Meyer, Philipp
Becker, Georg
Hesse, Swen
Patt, Marianne
Seese, Anita
Gertz, Hermann-Josef
Schwarz, Johannes
Sabri, Osama
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[8] Nicotinic acetylcholine receptor (α4β2*) binding in Parkinson's disease (PD) with mild cognitive impairment using 2-[F-18]F-A-85380 (2FA) PET
Meyer, Philipp
Hesse, Swen
Becker, Georg
Kendziorra, Kai
Wegner, Florian
Schwarz, Johannes
Sabri, Osama
JOURNAL OF NUCLEAR MEDICINE, 2009, 50
[9] Association between lower α4β2*nicotinic acetylcholine receptor binding and nonmotor symptoms in early drug naive Parkinson disease: A 2-[18F]F-A-85380 (2FA) PET study
Meyer, Philipp
Becker, Georg
Kendziorra, Kai
Wegner, Florian
Strecker, Karl
Patt, Marianne
Hesse, Swen
Schwarz, Johannes
Sabri, Osama
JOURNAL OF NUCLEAR MEDICINE, 2010, 51
[10] Reduced α4β2*nicotinic acetylcholine receptor binding in acute unmedicated major depressive disorder using 2-[18F]F-A-85380 PET
Meyer, P. M.
Hegerl, U.
Hesse, S.
Becker, G. A.
Strauss, M.
Patt, M.
Luthardt, J.
Barthel, H.
Schoenknecht, P.
Sabri, O.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S216 - S216

← 1 2 3 4 5 →

Progressive deterioration of α4β2*nicotinic acetylcholine receptor (α4β2*-nAChR) binding in de novo Parkinson's disease: A 1-year follow-up 2-[18F]F-A-85380 (2-FA) PET study

Progressive deterioration of α4β2nicotinic acetylcholine receptor (α4β2-nAChR) binding in de novo Parkinson's disease: A 1-year follow-up 2-[18F]F-A-85380 (2-FA) PET study